Alessandro Campanella

Vita-Salute San Raffaele University — Italy

Medicine · Health Sciences

24h-index2.3kcitations53works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Iron Metabolism and Disorders(27), Trace Elements in Health(13), Hemoglobinopathies and Related Disorders(10), Chronic Lymphocytic Leukemia Research(8), Prostate Cancer Treatment and Research(5)

Publications53 total

Loss of CYLD promotes splenic marginal zone lymphoma
HemaSphere·2025· 2 citedOpen Access
Bone marrow <i>Tfr2</i> deletion improves the therapeutic efficacy of the activin‐receptor ligand trap RAP‐536 in β‐thalassemic mice
American Journal of Hematology·2024· 4 citedOpen Access
IκBε deficiency accelerates disease development in chronic lymphocytic leukemia
Leukemia·2024· 3 citedOpen Access
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS‐CoV‐2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL
American Journal of Hematology·2024· 10 citedOpen Access
P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 NATURAL INFECTION OR VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A STUDY BY ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL
HemaSphere·2023Open Access
P1225: CYLD, A NOVEL REGULATOR OF SPLENIC MARGINAL ZONE LYMPHOMA PATHOGENESIS
HemaSphere·2023Open Access
P1489: HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY AND IMPROVES IMMUNE ANTITUMOR FUNCTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
HemaSphere·2023· 1 citedOpen Access
Data from Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models
2023Open Access
Supplementary Data from Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models
2023Open Access
Data from Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models
2023Open Access
Supplementary Data from Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models
2023Open Access
CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
Clinical Lymphoma Myeloma & Leukemia·2022· 2 citedOpen Access
Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
Clinical Lymphoma Myeloma & Leukemia·2022Open Access
Rethinking experiential learning in design education: The shift of the systemic design course to a multimodal online learning environment
2021Open Access
Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models
Clinical Cancer Research·2020· 73 citedOpen Access
Iron Causes Lipid Oxidation and Inhibits Proteasome Function in Multiple Myeloma Cells: A Proof of Concept for Novel Combination Therapies
Cancers·2020· 39 citedOpen Access
Targeting the BMP Receptor Inhibitor FKBP12 to Upregulate Hepcidin in Wild-Type and Hemojuvelin-Hemochromatosis Models
Blood·2019
S1628 TARGETING THE IMMUNOPHILIN FKBP12 BY DRUG REPURPOSING OR RNASE‐BASED APPROACHES FOR BMP‐SMAD PATHWAY AND HEPCIDIN UPREGULATION IN HEREDITARY HEMOCHROMATOSIS
HemaSphere·2019Open Access
PF369 EXPLOITING IRON TOXICITY TO INCREASE VULNERABILITY OF MALIGNANT B CELLS
HemaSphere·2019Open Access
Inhibiting the Immunophilin FKBP12: A Potential Therapeutic Approach to Iron Overload/Low Hepcidin Disorders
Blood·2018
page 1 of 3Next →

Frequent Co-authors

Clara Camaschella(18), Jessica Bordini(18), Paolo Ghia(15), Paolo Santambrogio(14), Sonia Levi(12), Alessia Pagani(11), Laura Silvestri(9), Michela Frenquelli(9), Anna Cozzi(8), Pamela Ranghetti(8), Lydia Scarfò(8), Paolo Arosio(7), Antonella Nai(7), Federica Morisi(6), Elisabetta Albi(6), Eleonora Perotta(6), Angela Rita Elia(5), Vito Cucchiara(5), Matteo Bellone(5), Alberto Briganti(5)